LMHFV was found to mitigate sarcopenia by modulating mitochondrial homeostasis, such as attenuating mitochondrial morphological deterioration and improving mitochondrial biogenesis through increasing PGC‐1α via inhibiting miR‐378 in skeletal muscle. This evidence concerns the gene PPARGC1A and sarcopenia.